Founded in 1992, it is a well-known trademark in Guangdong Province and a private pharmaceutical group with strong comprehensive strength in China, with well-known products in the market such as Mrs. Oral Liquid and Livzon Dele
Jianxingyuan Pharmaceutical Group Co., Ltd. (hereinafter referred to as Jianxingyuan Pharmaceutical Group) was formerly known as Shenzhen Taitai Health Food Co., Ltd. Founded by Chairman Zhu Baoguo in 92, it has established a leading position in the health care products industry by relying on a dose of "Mrs. Oral Liquid"; In 95 years, the strategic transformation entered the pharmaceutical industry and was renamed Shenzhen Taitai Pharmaceutical Co., Ltd.; In 97, it acquired Shenzhen Haibin Pharmaceutical Co., Ltd. to complete the successful transformation from a health care product company to a pharmaceutical company; In 99, the shareholding system reform was completed and changed to Shenzhen Taitai Pharmaceutical Co., Ltd.; In 2001, Taitai Pharmaceutical was listed on the Shanghai Stock Exchange and successfully listed. After that, Jianxingyuan Pharmaceutical Group successively acquired high-quality pharmaceutical companies such as Health Pharmaceutical (China) Co., Ltd. and Livzon Pharmaceutical Group Co., Ltd.; In 2003, it was renamed Jiankang Yuan Pharmaceutical Group Co., Ltd. Relying on years of focusing on the operation of the pharmaceutical field, Jianxingyuan Pharmaceutical Group has developed from a well-known health care product enterprise to a private pharmaceutical group with strong comprehensive strength in China.
At present, Jianxingyuan Pharmaceutical Group has more than 30 major holding subsidiaries, more than 500 drug varieties and more than 8,000 employees, and its business scope covers health care products, APIs (including intermediates) and preparations, prescription drugs and over-the-counter drugs, Chinese patent medicines and chemical preparations, testing reagents and other fields, and has begun to form an upstream and downstream industrial chain. Health care products have well-known brands such as Mrs., Jingxin, and Eagle; APIs (intermediates) include antibiotic series and their intermediates 7ACA (enzymatic method), 4AA, F9, etc.; Prescription drugs include digestive tract drugs, cardiovascular and cerebrovascular drugs, anti-infective drugs, anti-tumor drugs, neurocerebrovascular drugs, urinary system drugs and other fields; Over-the-counter drugs include gastrointestinal drugs "Livzon Dela" and "Livzon Intestinal Music", oral ulcer drugs "Yike Patch", cold drugs "Antiviral Oral Granules", skin topical drugs "Xinfu Mitesin Ointment", compound dexamethasone acetate cream, etc. In 2009, the total amount of drugs purchased by hospitals in China ranked 5th among domestic enterprises, and 12th among foreign companies (IMS data shows). Jianxingyuan Pharmaceutical Group's products are also exported to the United States, Australia, Singapore, Malaysia, Hong Kong, Macao and Taiwan.
Shenzhen Haibin Pharmaceutical Co., Ltd., a subsidiary of Jianxingyuan Pharmaceutical Group, mainly produces and sells antibiotics, and takes the third-generation antibiotic carbapenems as the main development direction, and is now the world's largest carbapenem antibiotic production base. Following the 2011 Haibin Pharmaceutical sterile meropenem (API) through the EU GMP certification and the 2012 sterile meropenem (powder for injection) through the EU GMP certification, at the beginning of 2014, Haibin Pharmaceutical sterile meropenem obtained the EU CEP certificate, so far, Haibin Pharmaceutical has become the first domestic sterile meropenem through the European CEP certification unit, and is also the current domestic EU EU-GMP certification of sterile APIs, sterile preparations (powder for injection), European CEP certified sterile API three-in-one production unit.
In 2007, Jiaozuo Jianxingyuan Biological Products Co., Ltd., a subsidiary of Jianxingyuan Pharmaceutical Group, was the first environmentally friendly "enzymatic" method in China to industrialize the production of 7-aminocephalosporinic acid (abbreviated as 7-ACA), a key intermediate of cephalosporins, leading the industry's production process from chemical method to environmentally friendly enzymatic method, and has now become the industry leader.
Xinxiang Haibin Pharmaceutical Co., Ltd., a subsidiary of Jianxingyuan Pharmaceutical Group, produces meropenem intermediates 4AA and F9, imipenem cilastatin, etc., and is now a key enterprise in Xinxiang City, and is the main supplier of meropenem intermediates F9 and 4AA of Shenzhen Haibin Pharmaceutical Co., Ltd.
